151 related articles for article (PubMed ID: 16708245)
1. Differential expression of spleen tyrosine kinase Syk isoforms in tissues: Effects of the microbial flora.
Duta F; Ulanova M; Seidel D; Puttagunta L; Musat-Marcu S; Harrod KS; Schreiber AD; Steinhoff U; Befus AD
Histochem Cell Biol; 2006 Oct; 126(4):495-505. PubMed ID: 16708245
[TBL] [Abstract][Full Text] [Related]
2. Spleen tyrosine kinase mediates high glucose-induced transforming growth factor-β1 up-regulation in proximal tubular epithelial cells.
Yang WS; Chang JW; Han NJ; Lee SK; Park SK
Exp Cell Res; 2012 Sep; 318(15):1867-76. PubMed ID: 22659134
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of syk transfection on lung cancer cell invasion.
Peng CL; Zhang Y; Sun QF; Zhao YP; Hao YT; Zhao XG; Cong B
Asian Pac J Cancer Prev; 2013; 14(5):3001-3. PubMed ID: 23803069
[TBL] [Abstract][Full Text] [Related]
4. Spleen Tyrosine Kinase Modulates Fibrous Airway Obliteration and Associated Lymphoid Neogenesis After Transplantation.
Matsuda Y; Wang X; Oishi H; Guan Z; Saito M; Liu M; Keshavjee S; Chow CW
Am J Transplant; 2016 Jan; 16(1):342-52. PubMed ID: 26308240
[TBL] [Abstract][Full Text] [Related]
5. Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia.
Goodman PA; Wood CM; Vassilev A; Mao C; Uckun FM
Oncogene; 2001 Jul; 20(30):3969-78. PubMed ID: 11494125
[TBL] [Abstract][Full Text] [Related]
6. The relationship between methylation of the Syk gene in the promoter region and the genesis of lung cancer.
Ma L; Dong S; Zhang P; Xu N; Yan H; Liu H; Li Y; Zhou Q
Clin Lab; 2010; 56(9-10):407-16. PubMed ID: 21086786
[TBL] [Abstract][Full Text] [Related]
7. Expression of putative tumor suppressor gene spleen tyrosine kinase in esophageal squamous cell carcinoma.
Dong SW; Zhang P; Zhong RR; Liu Q
Clin Lab; 2013; 59(5-6):647-53. PubMed ID: 23865365
[TBL] [Abstract][Full Text] [Related]
8. Myeloid cell-mediated renal injury in rapidly progressive glomerulonephritis depends upon spleen tyrosine kinase.
Ryan J; Ma FY; Han Y; Ozols E; Kanellis J; Tesch GH; Nikolic-Paterson DJ
J Pathol; 2016 Jan; 238(1):10-20. PubMed ID: 26251216
[TBL] [Abstract][Full Text] [Related]
9. Spleen tyrosine kinase (Syk) inhibitor fostamatinib limits tissue damage and fibrosis in a bleomycin-induced scleroderma mouse model.
Pamuk ON; Can G; Ayvaz S; Karaca T; Pamuk GE; Demirtas S; Tsokos GC
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S15-22. PubMed ID: 26148346
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of full-length spleen tyrosine kinase on invasion and metastasis of human laryngeal squamous cells].
Li Z; Cai Z; Tao B; Jin Q
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Nov; 49(11):943-9. PubMed ID: 25598376
[TBL] [Abstract][Full Text] [Related]
11. Spleen tyrosine kinase (Syk) is a potent target for GvHD prevention at different cellular levels.
Leonhardt F; Zirlik K; Buchner M; Prinz G; Hechinger AK; Gerlach UV; Fisch P; Schmitt-Gräff A; Reichardt W; Zeiser R
Leukemia; 2012 Jul; 26(7):1617-29. PubMed ID: 22301676
[TBL] [Abstract][Full Text] [Related]
12. [Construction of the eukaryotic expression vector of human syk and its effect on MHC-I expression of human breast cancer cells].
Shan BE; Song XT; Qi YX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jan; 24(1):3-5. PubMed ID: 18177606
[TBL] [Abstract][Full Text] [Related]
13. [Functions of spleen tyrosine kinase (Syk) gene and its correlation to neoplasms].
Wang HY; Zhang ZX
Ai Zheng; 2007 May; 26(5):555-60. PubMed ID: 17672952
[TBL] [Abstract][Full Text] [Related]
14. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
Li J; Sidell N
Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
[TBL] [Abstract][Full Text] [Related]
15. Expression and methylation status of the Syk gene in cervical carcinoma.
Zhao S; Sun G; Tony PW; Ma D; Zhao C
Arch Gynecol Obstet; 2011 May; 283(5):1113-9. PubMed ID: 20563729
[TBL] [Abstract][Full Text] [Related]
16. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.
Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL
Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655
[TBL] [Abstract][Full Text] [Related]
17. Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation.
Wu NL; Huang DY; Wang LF; Kannagi R; Fan YC; Lin WW
J Invest Dermatol; 2016 Jan; 136(1):192-201. PubMed ID: 26763439
[TBL] [Abstract][Full Text] [Related]
18. Syk and Src are major pharmacological targets of a Cerbera manghas methanol extract with kaempferol-based anti-inflammatory activity.
Jeong HY; Sung GH; Kim JH; Yoon JY; Yang Y; Park JG; Kim SH; Yi YS; Yang WS; Yoon DH; Kim TW; Kim JH; Cho JY
J Ethnopharmacol; 2014 Feb; 151(2):960-9. PubMed ID: 24342777
[TBL] [Abstract][Full Text] [Related]
19. Sporadic mutations and expression analysis of spleen tyrosine kinase gene in breast cancer: a preliminary report.
Inayat U; Kayani MA; Faryal R
Pol J Pathol; 2012 Jun; 63(2):106-11. PubMed ID: 22864779
[TBL] [Abstract][Full Text] [Related]
20. Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma.
Ogane S; Onda T; Takano N; Yajima T; Uchiyama T; Shibahara T
Int J Cancer; 2009 Jun; 124(11):2651-7. PubMed ID: 19195024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
